Sonidegib

ATC L01XJ02 · 5 markets · 8 records

Sonidegib 5 markets · 8 records Forms

AU 4 records · 3 strengths

200 mgcapsuleOdomzo also in US·CA·ES
280.8 mgcapsuleODOMZO sonidegib diphosphate 200 mg hard capsule blister pack+1ODOMZO sonidegib diphosphate 200mg hard capsule bottle unknown

Records without a stated strength · 1 Odomzo

US 1 records · 1 strengths

200 mgcapsuleOdomzo also in AU·CA·ES

CA 1 records · 1 strengths

200 mgcapsuleOdomzo also in AU·US·ES

ES 1 records · 1 strengths

200 mgcapsuleOdomzo also in AU·US·CA

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Odomzo

Side-by-side table

Strength / form / release	US	CA	AU	ES	EU
200 mg capsule	Odomzo	Odomzo	Odomzo	Odomzo	not recorded
280.8 mg capsule	not recorded	not recorded	ODOMZO sonidegib diphosphate 200 mg hard capsule blister pack ODOMZO sonidegib diphosphate 200mg hard capsule bottle	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	Odomzo	not recorded	Odomzo

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.